Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 44.64 | 37.93 | 36.41 | 25.11 |
Depreciation/ Depletion | 26.44 | 32.30 | 33.53 | 35.28 |
Non- Cash Items | -6.21 | -8.97 | -6.31 | 10.78 |
Changesin Working Capital | -27.59 | -24.63 | -22.63 | 60.67 |
Cashfrom Operating Activities | 37.28 | 36.63 | 41.00 | 131.84 |
Capital Expenditures | -13.52 | -7.82 | -13.71 | -7.73 |
Other Investing Cash Flow Items Total | 6.31 | -43.01 | -2.92 | 64.22 |
Cashfrom Investing Activities | -7.21 | -50.83 | -16.63 | 56.49 |
Financing Cash Flow Items | -0.09 | -0.12 | -0.46 | -7.02 |
Issuance( Retirement)of Debt Net | -0.99 | -0.45 | -9.02 | -168.97 |
Cashfrom Financing Activities | -1.08 | -0.57 | -9.48 | -162.24 |
Foreign Exchange Effects | -1.25 | -7.27 | -0.52 | 0.85 |
Net Changein Cash | 27.74 | -22.04 | 14.38 | 26.94 |
Cash Interest Paid | 0.09 | 0.12 | 0.18 | 7.01 |
Cash Taxes Paid | 15.48 | - | - | - |
Issuance( Retirement)of Stock Net | - | - | 0.00 | 13.75 |
Venus Remedies Dividend Venus Remedies Bonus Venus Remedies News Venus Remedies AGM Venus Remedies Rights Venus Remedies Splits Venus Remedies Board Meetings Venus Remedies Key Metrics Venus Remedies Shareholdings Venus Remedies Profit Loss Venus Remedies Balance Sheet Venus Remedies Q1 Results Venus Remedies Q2 Results Venus Remedies Q3 Results Venus Remedies Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks